ELUTIA INC. - CLASS A COMMON STOCK

Aziyo Biologics Announces Funding of Additional $4 Million Term Loan with SWK Holdings Corporation

15 дек 2022 07:00:01 Источник Nasdaq GlobeNewswire

Aziyo Biologics, Inc. Announces Pricing of $11.2 Million Public Offering of Common Stock

01 дек 2022 08:04:00 Источник Nasdaq GlobeNewswire

Aziyo Biologics, Inc. Announces Proposed Public Offering of Common Stock

30 ноя 2022 15:08:00 Источник Nasdaq GlobeNewswire

Aziyo Biologics to Participate in Upcoming Investor Conferences

21 ноя 2022 15:05:00 Источник Nasdaq GlobeNewswire

Aziyo Biologics Reports Strong Third Quarter 2022 Revenue

14 ноя 2022 15:01:00 Источник Nasdaq GlobeNewswire

Aziyo Biologics to Report Third Quarter 2022 Financial Results on November 14, 2022

07 ноя 2022 15:05:01 Источник Nasdaq GlobeNewswire

Aziyo Biologics Appoints Seasoned Healthcare Executive, David Colpman, to Board of Directors

24 окт 2022 07:00:01 Источник Nasdaq GlobeNewswire

Aziyo Biologics Strengthens Leadership Team and Organizes for Growth in Key Markets

11 окт 2022 15:35:48 Источник Nasdaq GlobeNewswire

Aziyo Biologics Appoints Michelle LeRoux Williams, Ph.D as Chief Scientific Officer

26 авг 2022 08:00:00 Источник Nasdaq GlobeNewswire

Aziyo Biologics to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase

17 авг 2022 15:05:00 Источник Nasdaq GlobeNewswire

Aziyo Biologics Announces Second Quarter 2022 Financial Results and Recent Business Achievements, Including Robust Revenue Growth and Strengthened Balance Sheet

11 авг 2022 15:05:02 Источник Nasdaq GlobeNewswire

Aziyo Biologics Announces $25 Million Loan Facility with SWK Holdings

10 авг 2022 17:56:35 Источник Nasdaq GlobeNewswire

Aziyo Biologics Co-Founder and Regenerative Medicine Pioneer, Dr. Randy Mills, appointed Chief Executive Officer

09 авг 2022 16:57:55 Источник Nasdaq GlobeNewswire

Aziyo Biologics to Report Second Quarter 2022 Financial Results on August 11, 2022

28 июл 2022 15:05:00 Источник Nasdaq GlobeNewswire

Aziyo Biologics Appoints Dr. C. Randal Mills as Interim President and CEO

21 июн 2022 15:05:00 Источник Nasdaq GlobeNewswire

Aziyo Biologics Provides Business Update and Reports First Quarter 2022 Financial Results

09 май 2022 15:05:02 Источник Nasdaq GlobeNewswire

Aziyo Biologics to Report First Quarter 2022 Financial Results on Monday, May 9, 2022

25 апр 2022 15:05:00 Источник Nasdaq GlobeNewswire

Aziyo Biologics Announces Upcoming KOL Call Hosted by Cowen

12 апр 2022 15:05:00 Источник Nasdaq GlobeNewswire

Aziyo Announces FDA 510(k) Submission for CanGaroo® RM, its Next-Generation Biomaterial Envelope Enhanced with Antibiotics

04 апр 2022 07:00:02 Источник Nasdaq GlobeNewswire

Aziyo Biologics to Participate in the Lytham Partners Spring 2022 Investor Conference

31 мар 2022 17:50:00 Источник Nasdaq GlobeNewswire